2 stories from 2 sources
Day’s Recap is unavailable for this topic and date. Feel free to go through our curated list of stories below.
A curated list of other prominent stories from this day.
Researchers at the Alzheimer’s conference shifted attention toward tau biology and tau-targeting therapies, alongside updates on methods to deliver drugs across the blood-brain barrier. The reporting flags these as emerging focal points as the field looks beyond amyloid-only strategies.
4:01 PMStat NewsMenopause and broader midlife women's health have been underfunded and under-treated for decades despite affecting roughly half the population and driving large productivity losses. Celebrities, venture-backed startups, and a loosening of FDA-era stigma around hormone therapy are now pulling the category into a fast-growing, $360 billion women's health market, even as low-evidence wellness offerings proliferate.
10:04 AMBloomberg MarketsSummary
Researchers at the Alzheimer’s conference shifted attention toward tau biology and tau-targeting therapies, alongside updates on methods to deliver drugs across the blood-brain barrier. The reporting flags these as emerging focal points as the field looks beyond amyloid-only strategies.
Why it matters
A tau-and-delivery pivot could reset Alzheimer’s R&D priorities and determine whether the next wave of drugs produces meaningful clinical improvement.
Summary
Menopause and broader midlife women's health have been underfunded and under-treated for decades despite affecting roughly half the population and driving large productivity losses. Celebrities, venture-backed startups, and a loosening of FDA-era stigma around hormone therapy are now pulling the category into a fast-growing, $360 billion women's health market, even as low-evidence wellness offerings proliferate.
Why it matters
Menopause care is turning from a neglected clinical gap into a major healthcare market, and the quality bar set now will shape outcomes, costs, and workplace productivity.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!